How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

9,636 results for

Ideal Weight in Adults

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. The Role of Weight Management in the Treatment of Adult Obstructive Sleep Apnea Guideline

The Role of Weight Management in the Treatment of Adult Obstructive Sleep Apnea Guideline AMERICANTHORACICSOCIETY DOCUMENTS TheRoleofWeightManagementintheTreatmentofAdultObstructive Sleep Apnea An Of?cial American Thoracic Society Clinical Practice Guideline David W. Hudgel, Sanjay R. Patel, Amy M. Ahasic, Susan J. Bartlett, Daniel H. Bessesen, Melisa A. Coaker, P. Michelle Fiander, Ronald R. Grunstein, Indira Gurubhagavatula, Vishesh K. Kapur, Christopher J. Lettieri, Matthew T. Naughton (...) Unsuccessful in Losing Weight with Lifestyle Intervention? Discussion What Others Are Saying Putting It All Together Future Research Conclusions Overview Although previously developed guidelines on the treatment of adult obstructive sleep apnea(OSA)recommendedweightlossfor patients who are overweight or obese, detailed analyses of the impact of weight- loss therapies on OSA and its sequelae, as well as recommendations on speci?c weight management strategies, were not provided. The purpose of this clinical

2018 American Thoracic Society

2. Ideal Weight in Adults

Ideal Weight in Adults Ideal Weight in Adults Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Ideal Weight in Adults Ideal Weight (...) in Adults Aka: Ideal Weight in Adults , Ideal Body Weight in Adults , Ideal Weight , Ideal Body Weight , Predicted Weight , Predicted Body Weight for Height II. Indications Patient height must be at least 60 inches (5 feet) or 152.4 cm for these Ideal Body Weight calculations III. Calculation: Male Ideal Weight (Devine, 1974), Predicted Body Weight (PBW) used in -NET calculation Weight (kg) = 50 + 2.3 * (htIn - 60) Weight (kg) = 50 + 0.91 * (htCm - 152.4) Ideal Weight (Robinson, 1983) Weight (kg) = 52

2018 FP Notebook

3. Weight management: lifestyle services for overweight or obese adults

Weight management: lifestyle services for overweight or obese adults W Weight management: lifestyle services eight management: lifestyle services for o for ov verweight or obese adults erweight or obese adults Public health guideline Published: 28 May 2014 nice.org.uk/guidance/ph53 © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent (...) . Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Weight management: lifestyle services for overweight or obese adults (PH53) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk

2014 National Institute for Health and Clinical Excellence - Clinical Guidelines

4. Efficacy and Safety of Sugammadex Dosed According to Actual Body Weight (ABW) or Ideal Body Weight (IBW) in Reversal of Neuromuscular Blockade (NMB) in Morbidly Obese Participants (MK-8616-146)

Efficacy and Safety of Sugammadex Dosed According to Actual Body Weight (ABW) or Ideal Body Weight (IBW) in Reversal of Neuromuscular Blockade (NMB) in Morbidly Obese Participants (MK-8616-146) Efficacy and Safety of Sugammadex Dosed According to Actual Body Weight (ABW) or Ideal Body Weight (IBW) in Reversal of Neuromuscular Blockade (NMB) in Morbidly Obese Participants (MK-8616-146) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting (...) registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Efficacy and Safety of Sugammadex Dosed According to Actual Body Weight (ABW) or Ideal Body Weight (IBW) in Reversal of Neuromuscular Blockade (NMB) in Morbidly Obese Participants (MK-8616-146) The safety and scientific validity of this study is the responsibility of the study

2017 Clinical Trials

5. Anesthetic Cost Analysis With Desflurane in Two Different Fresh Gas Flows Adjusted to Ideal Body Weight

) determined according to ideal body weight. Condition or disease Safety Issues Detailed Description: After the ethical approvel 40 adult patients scheduled for hepatectomy will be taken to study. Patients will be monitored after they are taken to the operating room (ECG, NIBP, SpO2, Body Temp, BIS, NIRS, PVI, PI, ORI). After the anesthesia induction and tarakeal entubation, first twenty patient will take 5 mL/kg fresh gas flow (group 1), hemodynamic and gas consumption data will be recorded. Second twenty (...) Anesthetic Cost Analysis With Desflurane in Two Different Fresh Gas Flows Adjusted to Ideal Body Weight Anesthetic Cost Analysis With Desflurane in Two Different Fresh Gas Flows Adjusted to Ideal Body Weight - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2018 Clinical Trials

6. A Trial of the Ideal Protein System Versus Low Fat Diet for Weight Loss

, 2018 See Sponsor: Tulane University Collaborator: Ideal Protein Information provided by (Responsible Party): Lydia A. Bazzano, Tulane University Study Details Study Description Go to Brief Summary: This study will examine whether, compared to a standard, low-fat, calorie-restricted diet intervention, the clinic-supported Ideal Protein weight loss method will result in greater weight loss and improvement in cardiometabolic risk factors over 3 months among obese adults with cardiovascular disease (...) (CVD) risk factors. Condition or disease Intervention/treatment Phase Weight Loss Behavioral: Ideal Protein Weight Loss Method Behavioral: Standard Weight Loss Not Applicable Detailed Description: Restricting total calorie intake is emphasized in the 2013 American Heart Association/ American College of Cardiology/ The Obesity Society Guideline (AHA/ACC/TOS) for the Management of Overweight and Obesity in Adults for its effectiveness at reducing body weight and decreasing cardiometabolic risk

2018 Clinical Trials

7. Chrono-nutrition and weight loss - does eating more later in the day increase weight and decrease weight loss success in adults

Chrono-nutrition and weight loss - does eating more later in the day increase weight and decrease weight loss success in adults Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any (...) ruler software. In case data are not reported or unclear, we will attempt to contact authors by e-mail (max. 2 attempts). In case an outcome is measured at multiple time points, data from the time point where efficacy is highest will be included. ">Methods for data extraction Example: Experimental groups, control group(s) and number of animals per group. ">Data to be extracted: study design Example: Species, sex, weight, age, co‐morbidity, anaesthetic agent used, method of induction of cardiac

2020 PROSPERO

8. Six-month changes in ideal cardiovascular Health vs. Framingham 10-year coronary heart disease Risk among young adults enrolled in a weight loss intervention. Full Text available with Trip Pro

Six-month changes in ideal cardiovascular Health vs. Framingham 10-year coronary heart disease Risk among young adults enrolled in a weight loss intervention. The Framingham Risk equation uses sex, age, smoking, total cholesterol, high-density lipoprotein (HDL) cholesterol and systolic blood pressure to predict 10-year risk of coronary heart disease (FR-10). The American Heart Association's Ideal Cardiovascular Health (IDEAL) score uses smoking, total cholesterol, fasting glucose, blood (...) pressure, body mass index (BMI), diet, and physical activity to encourage a healthy cardiovascular phenotype. This study aimed to compare 6-month changes in the FR-10 vs. IDEAL score among young adults with BMI ≥25 to <40kg/m(2) enrolled in a behavioral weight loss intervention at the University of Pittsburgh (2010-12). Medians [25th, 75th percentiles] are reported. Weight decreased by 8kg [-12, -4] among 335 participants. Of 7 possible points, IDEAL score was 4 [3, 4] at baseline, improved (i.e

2016 Preventive Medicine

9. Ideals versus reality: Are weight ideals associated with weight change in the population? (Abstract)

Ideals versus reality: Are weight ideals associated with weight change in the population? To quantify weight ideals of young adults and to examine whether the discrepancy between actual and ideal weight is associated with 10-year body mass index (BMI) change in the population.This study comprised 4,964 adults from the prospective population-based FinnTwin16 study. They reported their actual and ideal body weight at age 24 (range 22-27) and 10 years later (attrition 24.6%). The correlates (...) of discrepancy between actual and ideal body weight and the impact on subsequent BMI change were examined.The discrepancy between actual and ideal weight at 24 years was on average 3.9 kg (1.4 kg/m(2) ) among women and 1.2 kg (0.4 kg/m(2) ) among men. On average, participants gained weight during follow-up irrespective of baseline ideal weight: women ¯x = +4.8 kg (1.7 kg/m(2) , 95% CI 1.6-1.9 kg/m(2) ), men ¯x = +6.3 kg (2.0 kg/m(2) , 95% CI 1.8-2.1 kg/m(2) ). Weight ideals at 24 years were not correlated

2016 Obesity

10. The Effect of Sugammadex Given Based on Ideal, Actual or Adjusted Body Weight on Reversal of Rocuronium.

The Effect of Sugammadex Given Based on Ideal, Actual or Adjusted Body Weight on Reversal of Rocuronium. The Effect of Sugammadex Given Based on Ideal, Actual or Adjusted Body Weight on Reversal of Rocuronium. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. The Effect of Sugammadex Given Based on Ideal, Actual or Adjusted Body Weight on Reversal of Rocuronium. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03381209 Recruitment Status : Completed First Posted : December 21, 2017 Last Update Posted

2017 Clinical Trials

11. Comparison of Ideal vs. Actual Weight Base Factor Dosing

Comparison of Ideal vs. Actual Weight Base Factor Dosing Comparison of Ideal vs. Actual Weight Base Factor Dosing - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Comparison of Ideal vs. Actual Weight Base (...) prevention and cessation. This study also examines ways to prevent delivering excessive factor by using a patient's ideal body weight as a new dosing strategy compared to the current dosing strategy. The hypothesis being tested is that factor dosing based on ideal body weight will result in protective factor levels. Condition or disease Intervention/treatment Phase Hemophilia A Other: Ideal Body Weight First Other: Actual Body Weight First Not Applicable Detailed Description: This is a randomized

2017 Clinical Trials

12. National Early Warning Score systems that alert to deteriorating adult patients in hospital

or aggregated weighted scoring systems used to set trigger thresholds locally. NEWS2 is recommended in the NICE guideline's section on choice of physiological track and trigger system as the system endorsed by NHS England. NHS England and NHS Improvement mandated NEWS2 for use for adults in acute and ambulance trusts by publishing a Patient Safety Alert for NEWS2 in April 2018 (last updated 9 December 2019), which highlighted resources to support its safe adoption. NEWS2 should not be used in children under (...) in the assignment of weights to measured SpO 2 (NEWS weights SpO 2 values below 96%; NEWS2 below 88%). Additionally, for patients with or at risk of T2RF when receiving oxygen, NEWS2 assigns weights for SpO 2 values above 92%. Among 251,266 adult admissions, 48,898 were identified to be at risk of T2RF by diagnostic coding. In this group, NEWS2 showed statistically significant lower discrimination (c-statistic; 95% CI) for identifying in-hospital mortality within 24 hours (0.860; 0.857 to 0.864) than NEWS

2020 National Institute for Health and Clinical Excellence - Advice

13. Space from Depression for treating adults with depression

Depression Difference Difference in cost in cost Guided self-help (3 to 6 sessions) £59 £54 £5 saved Group CBT £97 £54 £43 saved Workshop CBT £8 £54 £46 cost Face-to-face, individual CBT £560 £54 £506 saved Antidepressant medication for 6 months (weighted average cost based on minimum daily dose) £110 £54 £56 saved T able abbreviations: CBT, cognitive behavioural therapy. Space from Depression for treating adults with depression (MIB215) © NICE 2020. All rights reserved. Subject to Notice of rights (...) Space from Depression for treating adults with depression Space from Depression for treating adults with depression Medtech innovation briefing Published: 7 May 2020 www.nice.org.uk/guidance/mib215 pathways Expert panel conclusions Expert panel conclusions • Therapist and Improving Access to Psychological Therapies (IAPT) service feedback on Space from Depression (SilverCloud) was generally positive. The evaluation data and user feedback showed that it was an effective treatment for some users

2020 National Institute for Health and Clinical Excellence - Advice

14. Systematic review and meta-analysis of randomised controlled trials comparing face-to-face vs remote behaviour change interventions for weight management in adults carrying excess weight

Systematic review and meta-analysis of randomised controlled trials comparing face-to-face vs remote behaviour change interventions for weight management in adults carrying excess weight Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility (...) will extract data from graphs using digital ruler software. In case data are not reported or unclear, we will attempt to contact authors by e-mail (max. 2 attempts). In case an outcome is measured at multiple time points, data from the time point where efficacy is highest will be included. ">Methods for data extraction Example: Experimental groups, control group(s) and number of animals per group. ">Data to be extracted: study design Example: Species, sex, weight, age, co‐morbidity, anaesthetic agent used

2019 PROSPERO

15. The effects of exercise and dietary weight loss versus dietary weight loss alone on bone health in overweight and obese adults

The effects of exercise and dietary weight loss versus dietary weight loss alone on bone health in overweight and obese adults Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any (...) are not reported or unclear, we will attempt to contact authors by e-mail (max. 2 attempts). In case an outcome is measured at multiple time points, data from the time point where efficacy is highest will be included. ">Methods for data extraction Example: Experimental groups, control group(s) and number of animals per group. ">Data to be extracted: study design Example: Species, sex, weight, age, co‐morbidity, anaesthetic agent used, method of induction of cardiac ischemia, duration of ischemia and duration

2019 PROSPERO

16. Hypertension in adults: diagnosis and management

Hypertension in adults: diagnosis and management Hypertension in adults: diagnosis and Hypertension in adults: diagnosis and management management NICE guideline Published: 28 August 2019 www.nice.org.uk/guidance/ng136 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration (...) be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Hypertension in adults: diagnosis and management (NG136) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 40Contents Contents Overview 4 Who

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

17. AACE/ACE Guidelines for Management of Growth Hormone Deficiency in Adults and Patients Transitioning from Pediatric to Adult Care

hormone; ROC = receiver operating characteristic; RR = relative risk; SAH = subarachnoid hemorrhage; SDS = standard deviation score; SIR = standardized incidence ratio; SN = second- ary neoplasms; T3 = triiodothyronine; TBI = traumat- ic brain injury; VDBP = vitamin D-binding protein; WADA = World Anti-Doping Agency; WB-GST = weight-based glucagon stimulation test INTRODUCTION Adult growth hormone deficiency (GHD) results from decreased growth hormone (GH) secretion from the anterior pituitary gland (...) -point =5.0 mg/L) may be utilized, but if the test is contraindicated or not feasible to be performed, the GST (using a GH cut-point of 3 mg/L for normal-weight [BMI 30 kg/m 2 ] patients) and the macimorelin test (using a GH cut-point =2.8 mg/L) can be consid- ered as alternative tests (Grade C; BEL 2). R25. Arginine (ARG) and levodopa (L-DOPA) test- ing have not been systematically evaluated and vali- dated, and because these tests have low sensitivity and specificity in adults and transition

2019 American Association of Clinical Endocrinologists

18. Therapeutic guidelines for antiretroviral (ARV) treatment of adult HIV infection

therapy as soon as possible to reduce the risk of HIV transmission. THERAPEUTIC GUIDELINES FOR ANTIRETROVIRAL TREATMENT OF ADULT HIV INFECTION 7 VERSION: DEC 2019 RETURN TO TABLE OF CONTENTS Teratogenicity concerns and the potential for non-adherence due to morning sickness should be considered in selection and timing of antiretrovirals. Nausea and vomiting are common during pregnancy and ideally should be aggressively managed prior to initiating antiretrovirals (50-80% of pregnant individuals (...) Therapeutic guidelines for antiretroviral (ARV) treatment of adult HIV infection THERAPEUTIC GUIDELINES FOR ANTIRETROVIRAL TREATMENT OF ADULT HIV INFECTION VERSION: DEC 2019 THERAPEUTIC GUIDELINES ANTIRETROVIRAL (ARV) TREATMENT OF ADULT HIV INFECTION DECEMBER 2019 Prepared by: The Committee for Drug Evaluation and Therapy, British Columbia Centre for Excellence in HIV/AIDS (BC- CfE) Reviewed and endorsed by: Dr Julio Montaner, OC, OBC, MD, FRCPC, FCCP Director and Physician in Chief of the BC

2020 CPG Infobase

19. Canadian guidelines on cannabis use disorder among older adults

Canadian guidelines on cannabis use disorder among older adults 135 CANADIAN GERIATRICS JOURNAL, VOLUME 23, ISSUE 1, MARCH 2020 ABSTRACT Background Cannabis Use Disorder (CUD) is an emerging and diverse challenge among older adults. Methods The Canadian Coalition for Seniors’ Mental Health, with financial support from Health Canada, has produced evidence- based guidelines on the prevention, identification, assessment, and treatment of this form of substance use disorder. Conclusions Older (...) adults may develop CUD in the setting of recreational and even medical use. Clinicians should remain vigilant for the detection of CUD, and they should be aware of strategies for prevention and managing its emergence and consequences The full version of these guidelines can be accessed at www .ccsmh.ca. Key words: cannabis, substance use disorder, older adults INTRODUCTION In Canada, cannabis use rates in older adults have been ris- ing over the last decade as baby boomers age into their older years

2020 CPG Infobase

20. Effects of body fat mass and therapeutic weight loss on vitamin D status in privately owned adult dogs Full Text available with Trip Pro

Effects of body fat mass and therapeutic weight loss on vitamin D status in privately owned adult dogs More than one-third of humans and companion dogs in Western societies are overweight or obese. In people, vitamin D deficiency is widespread and associated with obesity, a now recognised inflammatory state. Low vitamin D status occurs in dogs with inflammatory conditions, but its relationship with obesity has not been investigated. In otherwise healthy privately owned adult dogs of ideal body (...) condition (control, n 7) and dogs with overweight to obese body condition (treatment, n 8), serum 25-hydroxyvitamin D (25(OH)D) concentration and body composition as inferred from 2H-labelled water dilution space were evaluated. Subsequently, the dogs were transitioned to a commercial canine therapeutic weight-loss diet; control dogs were fed to maintain body weight and treatment dogs were energy-restricted to achieve a safe weight-loss rate. Thereafter, serum 25(OH)D concentration was re-evaluated 8

2018 Journal of nutritional science

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>